The US Food and Drug Administration (FDA) announced the approval of 127 innovator and biosimilar drugs in 2024, a notable ...

French biotech One Biosciences has raised 15 million euros ($16 million) in series A financing to advance development of its ...

South Korea’s Samsung Bioepis today announced it has entered into a license, development and commercialization agreement (DCA ...

US companies SandboxAQ and iOncologi have announced a strategic collaboration to jointly develop, validate, and commercialize ...

Sweden’s OncoZenge has announced an amendment to its license and supply agreement with Italian firm Molteni Farmaceutici.

Swiss pharma giant Roche has won approval from the UK’s Medicines and Healthcare Regulatory Agency (MHRA) for its combination ...

UK pharma major GSK has gained US regulatory approval for a new prefilled syringe presentation of its shingles vaccine, ...

Artificial intelligence has edged past the pilot phase in clinical development. Once a niche add-on, AI is now helping ...

US rare disease meds developer Sarepta Therapeutics late yesterday announced a strategic restructuring plan designed to ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Kisqali (ribociclib) as an ...

Bayer (BAYN: DE) is giving chief executive Bill Anderson more time to deliver on his ambitious efforts to reshape the German ...

Swiss pharma giant Novartis this morning reported second quarter 2025 financial results, showing that net sales were $14.1 ...